| |
 |
Therapeutic Expertise |
|
|
 |

|
|
Synarc specializes in centralized image reading, subject recruitment, and consulting services for cardiology, neurovascular, and metabolic disease areas.
To date we have participated in 75 cardiology and neurovascular multinational and multicenter studies, including 21 ongoing studies. Please join the family of satisfied Synarc clients — contact us today.
Efficient and effective clinical-trial development and execution
From initial study design to regulatory submission, Synarc services are comprehensive and flexible, including onsite or remote image reading, and hard-copy or Web-based reporting. Our medical and scientific experts provide the direct hands-on expertise and guidance necessary to improve clinical-trial efficiency, reduce costs, and expedite product time to market.
Superior-quality centralized imaging
Synarc supports the use of all imaging modalities related to cardiology and neurovascular disease, including ultrasound, CT, MRI, x-ray, angiography, and
SPECT. Our systems are fully compliant with FDA CFR 21 Part 11 regulation. Synarc has a large network of academic cardiologists, neuroradiologists, and radiologists, all of whom have experience working with Synarc and receive ongoing training to ensure standardized, high-quality, reproducible reads. Our experts are appointed according to the reading specificity required.

Expertise in securing regulatory approval
Our considerable experience in obtaining approval for cardiology and neurovascular agents ensures that your data reach the regulatory agencies efficiently and in the most appropriate format for expeditious review and approval.
|
|
 |
Centralized Imaging Services for Cardiology and Neurovascular Diseases |
- Atherosclerosis
identification
and quantitation
- Cardiotoxicity
- DXA
- Left ventricular
mass and function
(heart failure)
- Lipodystrophy
and obesity
- Peripheral
vascular disease
(microcirculation)
- Stroke, brain injury,
SAH
- Thrombosis
- Vascular imaging
agents
|
|
 |
 |
Medical Directors |
|
|
 |
|
|